NEW YORK (GenomeWeb News) – Investigators at the
Rutgers Cancer Institute of New Jersey (CINJ) and the University of Wisconsin Carbone Cancer Center have won a $4.3 million grant from the National Cancer Institute to conduct a clinical trial seeking to identify and use genomic biomarkers to provide targeted cancer treatments, CINJ said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.